Trastuzumab
#
Find similar titles
- (rev. 3)
- Hyungyong Kim
Structured data
Trastuzumab (INN; trade names Herclon, Herceptin) is a Monoclonal antibody that interferes with the HER2/neu receptor. Its main use is to treat certain Breast cancers.
Table of Contents
Incoming Links #
Related Articles (Article 0) #
Related Medical Scholarly Articles (MedicalScholarlyArticle 1) #
- Biomarkers in triple negative breast cancer: A review
- Comprehensive molecular portraits of human breast tumours
- Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype
- The cancer genome
Related Books (Book 2) #
Related Drugs (Drug 3) #
Suggested Pages #
- 0.482 PIK3CA
- 0.035 Lung cancer
- 0.025 May 10
- 0.025 Personalized medicine
- 0.024 Progesterone receptor
- 0.023 Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response
- 0.023 Landscape of somatic mutations in 560 breast cancer whole-genome sequences
- 0.022 Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology
- 0.022 July 28
- 0.022 RMRP
- More suggestions...